These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 812435

  • 1. [Criteria of detection and treatment of rejection crises following human cardiac transplantation in a series of 10 cases].
    Rottembourg J, Gandjbakhch I, de Vernejoul P, Mollereau M, Kin G, Fauchet M, Guiraudon G, Christides C, Mattei MF, Luciani J, Legrain M, Cabrol C, Cabrol A.
    Arch Mal Coeur Vaiss; 1975 Aug; 68(8):801-4. PubMed ID: 812435
    [Abstract] [Full Text] [Related]

  • 2. [Human cardiac transplantation. Apropos of a case followed for more than 6 years].
    Henry E, Monties JR, Baille Y, Goudard A, Jausseran JM, Blanc T, Avierinos C, Cohen M, Serra P, Jouve A.
    Arch Mal Coeur Vaiss; 1975 Aug; 68(8):791-9. PubMed ID: 812434
    [Abstract] [Full Text] [Related]

  • 3. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths].
    Agozzino L, Thomopoulos K, Esposito S, Agozzino M, De Vivo F, Maiello C, Cotrufo M.
    Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868
    [Abstract] [Full Text] [Related]

  • 4. Heart transplantation in Arizona.
    Emery RW, Copeland JG.
    J Heart Transplant; 1985 Feb; 4(2):203-5. PubMed ID: 3916485
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sirolimus, a new potent immunosuppressant agent for refractory cardiac transplantation rejection: two case reports.
    Haddad H, MacNeil DM, Howlett J, O'Neill B.
    Can J Cardiol; 2000 Feb; 16(2):221-4. PubMed ID: 10694593
    [Abstract] [Full Text] [Related]

  • 7. Late complications in pediatric cardiac transplant recipients.
    Addonizio LJ, Hsu DT, Smith CR, Gersony WM, Rose EA.
    Circulation; 1990 Nov; 82(5 Suppl):IV295-301. PubMed ID: 2225419
    [Abstract] [Full Text] [Related]

  • 8. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR, Koch DM, Fisher SG, Heroux AL, Kao WG, Johnson MR.
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [Abstract] [Full Text] [Related]

  • 9. [Medium-term results of non-invasive follow-up after cardiac transplantation in childhood and in adolescence].
    Di Filippo S, Bozio A, Sassolas F, Champsaur G, Ninet J.
    Arch Mal Coeur Vaiss; 1997 May; 90(5):617-23. PubMed ID: 9295941
    [Abstract] [Full Text] [Related]

  • 10. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR, Ventura HO, Chambers RB, Ramireddy K, Smart FW, Stapleton DD.
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and treatment of acute cardiac allograft rejection.
    Oyer PE, Stinson EB, Bieber CP, Reitz BA, Raney AA, Baumgartner WA, Shumway NE.
    Transplant Proc; 1979 Mar; 11(1):296-303. PubMed ID: 377648
    [Abstract] [Full Text] [Related]

  • 12. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P, Fietze E, Döcke WD, Kern F, Ewert R, Volk HD.
    Transplantation; 1994 Jul 15; 58(1):35-41. PubMed ID: 7913561
    [Abstract] [Full Text] [Related]

  • 13. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
    Yamaura K, Ito K, Tsukioka K, Wada Y, Makiuchi A, Sakaguchi M, Akashima T, Fujimori M, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Suzuki J, Amano J, Isobe M.
    Circulation; 2004 Sep 21; 110(12):1650-7. PubMed ID: 15364799
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B, Kirali K, Göksedef D, Rabuş MB, Tuncer A, Erentuğ V, Mansuroğlu D, Yakut C.
    Anadolu Kardiyol Derg; 2008 Oct 21; 8(5):360-6. PubMed ID: 18849228
    [Abstract] [Full Text] [Related]

  • 15. [Coagulolytic system and graft rejection. (Experimental study of heart homotransplantation in rabbits)].
    Baille Y, Jausseran JM, Blanc T, Isman H, Goudard A, Sicard MP, Henry E, Payan H, Lebreuil G, Sudan M, Garbe C.
    Mars Med; 1972 Oct 21; 109(1):11-6. PubMed ID: 4553190
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New advances in antirejection therapy.
    Chan M, Pearson GJ.
    Curr Opin Cardiol; 2007 Mar 21; 22(2):117-22. PubMed ID: 17284990
    [Abstract] [Full Text] [Related]

  • 20. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
    De Maria R, Minoli L, Parolini M, Gavazzeni G, Gentile M, Grossi P, Livi U, Parisi F, Utili R.
    J Heart Lung Transplant; 1996 Feb 21; 15(2):124-35. PubMed ID: 8672515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.